SCHEMBL7274721

SCHEMBL7274721

COc1ccc(C2Sc3ccccc3N(CCN(C)C)CC2OC(C)=O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CACNA1S Q13698 7/20 0.66
▸ CYP3A4 P08684 3/20 0.66
▸ TSHR P16473 2/20 0.66
▸ ABCB11 O95342 2/20 0.66
▸ LMNA P02545 2/20 0.66
▸ KCNH2 Q12809 2/20 0.66
▸ SLC22A1 O15245 1/20 0.66
▸ CACNA1F O60840 1/20 0.66
▸ ABCB1 P08183 1/20 0.66
▸ HRH2 P25021 1/20 0.66
▸ ADRA1A P35348 1/20 0.66
▸ SCN1A P35498 1/20 0.66
▸ SCN4A P35499 1/20 0.66
▸ HTT P42858 1/20 0.66
▸ SCN7A Q01118 1/20 0.66
▸ CACNA1D Q01668 1/20 0.66
▸ PLAUR Q03405 1/20 0.66
▸ CACNA1C Q13936 1/20 0.66
▸ SCN5A Q14524 1/20 0.66
▸ SCN9A Q15858 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20957591 1.00 CACNA1S (0.66) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL7379847 0.89 CACNA1S (0.57) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL10608450 0.87 CACNA1S (0.57) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL9232281 0.85 CACNA1S (0.50) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL28517540 0.80 CYP3A4 (0.52) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL10506661 0.80 CACNA1S (0.47) CACNA1SCYP3A4TSHRABCB11LMNA
Diltiazem SCHEMBL676914 0.79 CACNA1S (1.00) CACNA1SCYP3A4TSHRABCB11LMNA
Diltiazem SCHEMBL4886734 0.79 CACNA1S (1.00) CACNA1SCYP3A4TSHRABCB11LMNA
Diltiazem SCHEMBL3468378 0.79 CACNA1S (1.00) CACNA1SCYP3A4TSHRABCB11LMNA
Diltiazem SCHEMBL614334 0.79 CACNA1S (1.00) CACNA1SCYP3A4TSHRABCB11LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0347987-A2 Tripeptide renin inhibitors with N-terminal carbamoyl or acyl groups MERCK & CO. INC. (US) 1989-12-27 — — EP claimed
EP-0314239-A2 Tripeptide renin inhibitors with N-terminal ureido or sulfamido groups MERCK & CO. INC. (US) 1989-05-03 — — EP claimed
EP-0312291-A2 Di-or tripeptide renin inhibitors containing lactam conformational restriction in ACHPA MERCK & CO. INC. (US) 1989-04-19 — — EP claimed
EP-0312158-A2 Tetrapeptide renin inhibitors having novel c-terminal amino acid amide MERCK & CO. INC. (US) 1989-04-19 — — EP claimed
WO-1991019499-A1 N-DESMETHYL - DEACETYL DILTIAZEM FOR USE IN REDUCING HYPERTENSION DUMONT LOUIS (CA) 1991-12-26 — — WO disclosed
EP-0347987-A2 Tripeptide renin inhibitors with N-terminal carbamoyl or acyl groups MERCK & CO. INC. (US) 1989-12-27 — — EP disclosed
EP-0314239-A2 Tripeptide renin inhibitors with N-terminal ureido or sulfamido groups MERCK & CO. INC. (US) 1989-05-03 — — EP disclosed
EP-0312291-A2 Di-or tripeptide renin inhibitors containing lactam conformational restriction in ACHPA MERCK & CO. INC. (US) 1989-04-19 — — EP disclosed
EP-0312157-A2 Tetrapeptide renin inhibitors having a novel c-terminal amino acid MERCK & CO. INC. (US) 1989-04-19 — — EP disclosed
EP-0312158-A2 Tetrapeptide renin inhibitors having novel c-terminal amino acid amide MERCK & CO. INC. (US) 1989-04-19 — — EP disclosed
EP-0312283-A2 Di-or tripeptide renin inhibitors containing lactam conformational restrictions in ACHPA MERCK & CO. INC. (US) 1989-04-19 — — EP disclosed
Send feedback